HRMY
Harmony Biosciences Holdings Inc
Price:  
34.33 
USD
Volume:  
569,367
United States | Pharmaceuticals

HRMY Net Margin

As of 2025-07-10, the Net Margin of Harmony Biosciences Holdings Inc (HRMY) is 20.3%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

HRMY Net Margin - Historical Value
DateValue
2024-12-31 20.3%
2023-12-31 22.2%
2022-12-31 41.4%
2021-12-31 11.3%
2020-12-31 -23.1%
2019-12-31 -2533.3%
2018-12-31 -
-
-
-
HRMY Net Margin - Peers Comparison